Stanford University: COVID-19 trials

The registry lists 28 COVID-19 studies with Stanford University as lead sponsor. 1 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 1 5Phase 2 9Phase 3 1No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Impact of the Coronavirus (COVID-19) on Patients With CancerRecruitingNCT04330521
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master ProtocolCompletedNCT04662086Phase 2Results posted
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-ProtocolTerminatedNCT04662073Phase 2Results posted
• COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-ProtocolCompletedNCT04662060Phase 2Results posted
• Rapid Turnaround, Home-based Saliva Testing for COVID-19CompletedNCT04568122Not applicableResults posted
• Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 PatientsCompletedNCT04524663Phase 2Results posted
• Convalescent Plasma in Outpatients With COVID-19CompletedNCT04355767Phase 3Results posted
• PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)CompletedNCT04347954Phase 1/2Results posted
• Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19CompletedNCT04346628Phase 2Results posted
• Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19CompletedNCT04331899Phase 2Results posted
• Reducing Respiratory Virus Transmission in Bangladeshi ClassroomsWithdrawnNCT06247059Not applicable
• Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in HomesCompletedNCT05777720Not applicable
• Understanding COVID-19 Vaccine Immunity in Tissue and BloodWithdrawnNCT05682625
• Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the CongoCompletedNCT05107479Not applicable
• Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSDActive, not recruitingNCT05037175Not applicable
• Pilot Study for PET/MR Imaging of Covid-19TerminatedNCT04954248Not applicable
• Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress SyndromeWithdrawnNCT04737161Phase 1
• Understanding Immunity to the COVID-19 VaccinesCompletedNCT04664309
• Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized PatientsWithdrawnNCT04570501Phase 1/2
• Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)CompletedNCT04567810Phase 1
• Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 PatientsWithdrawnNCT04480411Not applicable
• COVID-19 in Patients With Chronic Liver DiseasesCompletedNCT04439084
• Brief Telehealth CBT-I Intervention in the Context of the COVID-19 PandemicCompletedNCT04409743Not applicable
• Intranasal Injection of PRP Versus Saline for Treatment of Olfactory DysfunctionCompletedNCT04406584Not applicable
• Ulinastatin for the Treatment of COVID-19 in Hospitalized PatientsWithdrawnNCT04393311Phase 1/2
• Predicting Outcomes for Covid-19 Using SonographyCompletedNCT04384055
• Emergency Ventilator Splitting Between Two or More Patients (COVID-19)WithdrawnNCT04381013Not applicable
• Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CTCompletedNCT03183570Early Phase 1